Cheryl R. Blanchard - Mar 9, 2023 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role: President, CEO, Director, Director
Signature: /s/ Cheryl R. Blanchard
Stock symbol: ANIK
Transactions as of: Mar 9, 2023
Transactions value $: -$113,883
Form type: 4
Date filed: 3/10/2023, 03:51 PM
Previous filing: Mar 3, 2023
Next filing: Mar 14, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANIK	Common Stock	Options Exercise	$0	+14.4K	+19.61%	$0.00	88K	Mar 9, 2023	Direct	F1, F2
transaction	ANIK	Common Stock	Tax liability	-$114K	-4.23K	-4.81%	$26.91	83.7K	Mar 9, 2023	Direct	F3, F4
holding	ANIK	Common Stock						11.7K	Mar 9, 2023	Revocable Trust	F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANIK	Restricted Stock Unit	Award	$0	+60K		$0.00	60K	Mar 9, 2023	Common Stock	60K	$0.00	Direct	F6
transaction	ANIK	Stock Option (Right to Buy)	Award	$0	+131K		$0.00	131K	Mar 9, 2023	Common Stock	131K	$29.60	Direct	F7, F8
transaction	ANIK	Restricted Stock Unit	Options Exercise	$0	-14.4K	-50%	$0.00	14.4K	Mar 9, 2023	Common Stock	14.4K	$0.00	Direct	F9

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.
F2	Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 540 shares purchased on May 13, 2022 and 178 shares purchased on November 14, 2022.
F3	Reflects an aggregate of 4,232 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2023.
F4	Reflects the closing price of ANIK common stock on March 9, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
F5	Consists of shares transferred by Dr. Blanchard to The Cheryl R. Blanchard Amended and Restated Revocable Trust dated December 19, 2014, of which Dr. Blanchard is a beneficiary and the sole trustee.
F6	Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024.
F7	Represents a 10% premium above the closing price of Anika's common stock on the date of grant.
F8	The premium priced stock options vest in three equal annual installments beginning on March 9, 2024.
F9	Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022.